Clinical Trial Update: Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating short-term statin therapy for endothelial dysfunction following ischemia-reperfusion injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Ischemia-reperfusion Injury

Drugs mentioned

• Statin (statin)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Ischemia Reperfusion Injury, Endothelial Dysfunction | Phase 4 | Status: COMPLETED